AYTU BIOPHARMA, INC — Director's Dealing 2021

Apr 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOPHARMA, INC (AYTU)
CIK: 0001385818
Period of Report: 2021-04-08

Reporting Person: McLaughlin Gerald W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-08	Common Stock	A	6500	—	Acquired	31401	Direct

Footnotes

F1: Grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of AYTU common stock. The RSUs have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below).The RSUs vest as follows, and have no voting or dispositive rights until vested: one year vest from date of grant, April 8, 2021 such that the RSUs will be fully vested on April 8, 2022, subject to the reporting person's continuing employment with the Issuer.